Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Androgenetic alopecia in women needs more research and better management strategies.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.